controlled substances
DEA Proposes Rules to Govern Post-PHE Prescribing of Controlled Substances via “Telehealth”
On Friday, February 24, 2023, the Drug Enforcement Administration (DEA) released proposed rules intended to govern the prescribing of controlled substances via telemedicine for application at the end of the COVID-19 Public Health Emergency (PHE). The proposed rule — — Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a […]
Read MoreCMS Proposes Modifications to Requirements for Electronic Prescribing of Controlled Substances
We want to know what you think! Please submit any comments on this to Theresa Forster of the NAHC staff at tmf@nahc.org As part of the calendar year (CY) 2022 physician payment rule, the Centers for Medicare & Medicaid Services (CMS) promulgated significant regulations implementing Section 2003 of the Substance Use-Disorder Prevention That Promotes Opioid Recovery […]
Read MoreNAHC Supports Waiver of Electronic Prescribing Requirements for Part D-covered Controlled Substances Prescribed for Hospice Patients
The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT Act), enacted in 2018 to help combat the nation’s opioid epidemic, includes a requirement that prescriptions for controlled substances covered under Medicare Part D drug plans be electronically transmitted by a health care practitioner in accordance with an electronic […]
Read MoreGAO Report Examines Hospice Disposal of Controlled Substances
A new Government Accountability Office (GAO) report on disposal of controlled substances found substantial challenges for hospices, but also some key best practices that point the way toward new industry standards. According to the GAO report, challenges include the costs of certain disposal methods, a lack of a witness to the disposal process, and inconsistencies […]
Read More
